The fascinating effects of baicalein on cancer: A review

International Journal of Molecular Sciences

Volumn 17, Issue 10, 2016, Pages

  Liu, Hui ^a   Dong, Yonghui ^a   Gao, Yutong ^a   Du, Zhipeng ^a   Wang, Yuting ^a   Cheng, Peng ^a   Chen, Anmin ^a   Huang, Hui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Akt; Baicalein; Cancer; Flavonoids; MAPK; Reactive oxygen species (ROS); Therapy

Indexed keywords

BAICALEIN; CYCLIN DEPENDENT KINASE; EZRIN; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 70; LENALIDOMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PROTEIN BCL 2; PROTEIN KINASE B; SCUTELLARIAE RADIX; ANTINEOPLASTIC AGENT; CASPASE 9; FLAVANONE DERIVATIVE; MTOR PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; BLADDER CANCER; BONE DESTRUCTION; BREAST CANCER; CANCER THERAPY; CELL CYCLE REGULATION; COLORECTAL CANCER; DOWN REGULATION; HUMAN; HYPERVISCOSITY SYNDROME; MELANOMA SKIN CANCER; MULTIPLE MYELOMA; NEOPLASM; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; TUMOR INVASION; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; DRUG EFFECTS; METABOLISM; NEOPLASMS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 9; FLAVANONES; HUMANS; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; TOR SERINE-THREONINE KINASES;

EID: 84991383540     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17101681     Document Type: Review

References (101)

1. Bandhavkar, S. Cancer stem cells: A metastasizing menace! Cancer Med. 2016, 5, 649-655. [CrossRef] [PubMed]
2. Rodriguez-Galindo, C.; Friedrich, P.; Alcasabas, P.; Antillon, F.; Banavali, S.; Castillo, L.; Israels, T.; Jeha, S.; Harif, M.; Sullivan, M.J.; et al. Toward the cure of all children with cancer through collaborative efforts:Pediatric oncology as a global challenge. J. Clin. Oncol. 2015, 33, 3065-3073. [CrossRef] [PubMed]
3. 3) in the treatment of acute promyelocytic leukemia (APL) II. clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997, 89, 3354-3360. [PubMed]
4. Eckstein-Ludwig, U.;Webb, R.J.; van Goethem, I.D.; East, J.M.; Lee, A.G.; Kimura, M.; O’Neill, P.M.; Bray, P.G.; Ward, S.A.; Krishna, S. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003, 424, 957-961. [CrossRef] [PubMed]
5. Da Rocha, A.B.; Lopes, R.M.; Schwartsmann, G. Natural products in anticancer therapy. Curr. Opin. Pharmacol. 2001, 1, 364-369. [CrossRef]
6. Romano, B.; Pagano, E.; Montanaro, V.; Fortunato, A.L.; Milic, N.; Borrelli, F. Novel insights into the pharmacology of flavonoids. Phytother. Res. PTR 2013, 27, 1588-1596. [CrossRef] [PubMed]
7. Yao, H.; Xu,W.; Shi, X.; Zhang, Z. Dietary flavonoids as cancer prevention agents. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2011, 29, 1-31. [CrossRef] [PubMed]
8. Russo, M.; Spagnuolo, C.; Tedesco, I.; Russo, G.L. Phytochemicals in cancer prevention and therapy: Truth or dare? Toxins 2010, 2, 517-551. [CrossRef] [PubMed]
9. Wu, J.Y.; Tsai, K.W.; Li, Y.Z.; Chang, Y.S.; Lai, Y.C.; Laio, Y.H.; Wu, J.D.; Liu, Y.W. Anti-Bladder-Tumor Effect of Baicalein from Scutellaria baicalensis Georgi and Its Application in Vivo. Evid. Based Complement. Altern. Med. 2013, 2013, 579751. [CrossRef] [PubMed]
10. Ma, X.; Yan, W.; Dai, Z.; Gao, X.; Ma, Y.; Xu, Q.; Jiang, J.; Zhang, S. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Drug Des. Dev. Ther. 2016, 10, 1419-1441. [CrossRef] [PubMed]
11. Peng, Y.; Guo, C.; Yang, Y.; Li, F.; Zhang, Y.; Jiang, B.; Li, Q. Baicalein induces apoptosis of human cervical cancer HeLa cells in vitro. Mol. Med. Rep. 2015, 11, 2129-2134. [PubMed]
12. Rui, X.; Yan, X.I.; Zhang, K. Baicalein inhibits the migration and invasion of colorectal cancer cells via suppression of the AKT signaling pathway. Oncol. Lett. 2016, 11, 685-688. [CrossRef] [PubMed]
13. Zheng, Y.H.; Yin, L.H.; Grahn, T.H.; Ye, A.F.; Zhao, Y.R.; Zhang, Q.Y. Anticancer effects of baicalein on hepatocellular carcinoma cells. Phytother. Res. 2014, 28, 1342-1348. [CrossRef] [PubMed]
14. Chandrashekar, N.; Selvamani, A.; Subramanian, R.; Pandi, A.; Thiruvengadam, D. Baicalein inhibits pulmonary carcinogenesis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in vivo. Toxicol. Appl. Pharmacol. 2012, 261, 10-21. [CrossRef] [PubMed]
15. Guo, Z.; Hu, X.; Xing, Z.; Xing, R.; Lv, R.; Cheng, X.; Su, J.; Zhou, Z.; Xu, Z.; Nilsson, S.; et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Mol. Cell 2015, 406, 111-119. [CrossRef] [PubMed]
16. Li-Weber, M. New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 2009, 35, 57-68. [CrossRef] [PubMed]
17. He, X.;Wei, Z.; Zhou, E.; Chen, L.; Kou, J.;Wang, J.; Yang, Z. Baicalein attenuates inflammatory responses by suppressing TLR4 mediated NF-κB and MAPK signaling pathways in LPS-induced mastitis in mice. Int. Immunopharmacol. 2015, 28, 470-476. [CrossRef] [PubMed]
18. Yeh, C.H.; Ma, K.H.; Liu, P.S.; Kuo, J.K.; Chueh, S.H. Baicalein decreases hydrogen peroxide-induced damage to NG108-15 cells via upregulation of Nrf2. J. Cell. Physiol. 2015, 230, 1840-1851. [CrossRef] [PubMed]
19. Michaelis, M.; Sithisarn, P.; Cinatl, J., Jr. Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A. BMC Res. Notes 2014, 7, 384. [CrossRef] [PubMed]
20. Huang, Y.; Tsang, S.Y.; Yao, X.; Chen, Z.Y. Biological Properties of Baicalein in Cardiovascular System. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5, 177-184. [CrossRef] [PubMed]
21. Theodorescu, D. Molecular pathogenesis of urothelial bladder cancer. Histol. Histopathol. 2003, 18, 259-274. [PubMed]
22. National Cancer Institute. SEER Data. Available online: http://seer.cancer.gov/statfacts/ (accessed on 7 July 2016).
23. Morgan, T.M.; Keegan, K.A.; Clark, P.E. Bladder cancer. Curr. Opin. Oncol. 2011, 23, 275-282. [CrossRef] [PubMed]
24. Li, H.L.; Zhang, S.;Wang, Y.; Liang, R.R.; Li, J.; An, P.;Wang, Z.M.; Yang, J.; Li, Z.F. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells. Mol. Med. Rep. 2013, 7, 266-270. [CrossRef] [PubMed]
25. Chao, J.I.; Su,W.C.; Liu, H.F. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol. Cancer 2007, 6, 3039-3048. [CrossRef] [PubMed]
26. Jiang, R.H.; Su, W.C.; Liu, H.F.; Huang, H.S.; Chao, J.I. Opposite expression of securin and-H2AX regulates baicalein-induced cancer cell death. J. Cell. Biochem. 2010, 111, 274-283. [CrossRef] [PubMed]
27. Ikemoto, S.; Sugimura, K.; Kuratukuri, K.; Nakatani, T. Antitumor Effects of Lipoxygenase Inhibitors on Murine Bladder Cancer Cell Line (MBT-2). Anticancer Res. 2004, 24, 733-736. [PubMed]
28. 2+in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria-and caspase-3-dependent pathway. Anticancer Res. 2008, 28, 1701-1711. [PubMed]
29. Po, L.S.; Chen, Z.Y.; Tsang, D.S.; Leung, L.K. Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett. 2002, 187, 33-40. [CrossRef]
30. Wang, N.; Ren, D.; Deng, S.; Yang, X. Differential effects of baicalein and its sulfated derivatives in inhibiting proliferation of human breast cancer MCF-7 cells. Chem. Biol. Interact. 2014, 221, 99-108. [CrossRef] [PubMed]
31. Zhou, Q.M.; Wang, S.; Zhang, H.; Lu, Y.Y.; Wang, X.F.; Motoo, Y.; Su, S.B. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol. Sin. 2009, 30, 1648-1658. [CrossRef] [PubMed]
32. Wang, L.; Ling, Y.; Chen, Y.; Li, C.L.; Feng, F.; You, Q.D.; Lu, N.; Guo, Q.L. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 2010, 297, 42-48. [CrossRef] [PubMed]
33. Gao, X.Y.; Xue, X.H.; Ma, Y.N.; Zhang, S.Q. Effect of baicalein on the expression of SATB1 in human breast cancer cells. Exp. Ther. Med. 2015, 9, 1665-1669. [CrossRef] [PubMed]
34. Wang, Y.; Han, E.; Xing, Q.; Yan, J.; Arrington, A.; Wang, C.; Tully, D.; Kowolik, C.M.; Lu, D.M.; Frankel, P.H.; et al. Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. Cancer Lett. 2015, 358, 170-179. [CrossRef] [PubMed]
35. Peng, Y.; Li, Q.W.; Li, K.; Zhao, H.W.; Han, Z.S.; Li, F.L.; Sun, M.; Zhang, Y.X. Antitumor activity of baicalein on the mice bearing U14 cervical cancer. Afr. J. Biotechnol. 2011, 10, 14169-14176.
36. Tenesa, A.; Dunlop, M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 2009, 10, 353-358. [CrossRef] [PubMed]
37. Kim, S.J.; Kim, H.J.; Kim, H.R.; Lee, S.H.; Cho, S.D.; Choi, C.S.; Nam, J.S.; Jung, J.Y. Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells. Mol. Med. Rep. 2012, 6, 1443-1449. [PubMed]
38. Wang, C.Z.; Zhang, C.F.; Chen, L.; Anderson, S.; Lu, F.; Yuan, C.S. Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin. Int. J. Oncol. 2015, 47, 1749-1758. [CrossRef] [PubMed]
39. Kim, D.H.; Hossain, M.A.; Kang, Y.J.; Jang, J.Y.; Lee, Y.J.; Im, E.; Yoon, J.H.; Kim, H.S.; Chung, H.Y.; Kim, N.D. Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. Int. J. Oncol. 2013, 43, 1652-1658. [PubMed]
40. Huang, W.S.; Kuo, Y.H.; Chin, C.C.; Wang, J.Y.; Yu, H.R.; Sheen, J.M.; Tung, S.Y.; Shen, C.H.; Chen, T.C.; Sung, M.L.; et al. Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics 2012, 12, 810-819. [CrossRef] [PubMed]
41. Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127, 2893-2917. [CrossRef] [PubMed]
42. Mu, J.; Liu, T.; Jiang, L.;Wu, X.; Cao, Y.; Li, M.; Dong, Q.; Liu, Y.; Xu, H. The traditional Chinese medicine baicalein potently inhibits gastric cancer cells. J. Cancer 2016, 7, 453-461. [CrossRef] [PubMed]
43. Chen, F.; Zhuang, M.; Peng, J.; Wang, X.; Huang, T.; Li, S.; Lin, M.; Lin, H.; Xu, Y.; Li, J.; et al. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway. Mol. Med. Rep. 2014, 10, 1999-2003. [CrossRef] [PubMed]
44. Yan, X.; Rui, X.; Zhang, K. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol. Rep. 2015, 33, 737-743. [CrossRef] [PubMed]
45. Chen, F.; Zhuang, M.; Zhong, C.; Peng, J.; Wang, X.; Li, J.; Chen, Z.; Huang, Y. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway. Oncol. Rep. 2015, 33, 457-463. [CrossRef] [PubMed]
46. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.;Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90. [CrossRef] [PubMed]
47. Kuo, H.M.; Tsai, H.C.; Lin, Y.L.; Yang, J.S.; Huang, A.C.; Yang, M.D.; Hsu, S.C.; Chung, M.C.; Gihson Wood, W.; Chung, J.G. Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells. Int. J. Oncol. 2009, 35, 717-724. [PubMed]
48. Han, Z.; Zhu, S.; Han, X.; Wang, Z.; Wu, S.; Zheng, R. Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24. Int. Immunopharmacol. 2015, 29, 416-422. [CrossRef] [PubMed]
49. Zhou, Y.; Lu, N.; Zhang, H.; Wei, L.; Tao, L.; Dai, Q.; Zhao, L.; Lin, B.; Ding, Q.; Guo, Q. HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro. Eur. J. Pharm. Sci. 2013, 49, 649-658. [CrossRef] [PubMed]
50. Chiu, Y.W.; Lin, T.H.; Huang, W.S.; Teng, C.Y.; Liou, Y.S.; Kuo, W.H.; Lin, W.L.; Huang, H.I.; Tung, J.N.; Huang, C.Y.; et al. Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol. Appl. Pharmacol. 2011, 255, 316-326. [CrossRef] [PubMed]
51. Wang, Y.F.; Li, T.; Tang, Z.H.; Chang, L.L.; Zhu, H.; Chen, X.P.;Wang, Y.T.; Lu, J.J. Baicalein triggers autophagy and inhibits the protein kinase B/mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 Cells. Phytother. Res. 2015, 29, 674-679. [CrossRef] [PubMed]
52. Wang, Z.; Jiang, C.; Chen,W.; Zhang, G.; Luo, D.; Cao, Y.; Wu, J.; Ding, Y.; Liu, B. Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells. BioMed Res. Int. 2014, 2014, 732516. [CrossRef] [PubMed]
53. Chen, C.H.; Huang, T.S.;Wong, C.H.; Hong, C.L.; Tsai, Y.H.; Liang, C.C.; Lu, F.J.; Chang,W.H. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem. Toxicol. 2009, 47, 638-644. [CrossRef] [PubMed]
54. Martinez, C.; Yanez, J.; Vicente, V.; Alcaraz, M.; Benavente-Garcia, O.; Castillo, J.; Lorente, J.; Lozano, J.A. Effects of several polyhydroxylated flavonoids on the growth of B16F10 melanoma and Melan-A melanocyte cell lines: Influence of the sequential oxidation state of the flavonoid skeleton. Melanoma Res. 2003, 13, 3-9. [CrossRef] [PubMed]
55. Li, X.; Guo, L.; Sun, Y.; Zhou, J.; Gu, Y.; Li, Y. Baicalein inhibits melanogenesis through activation of the ERK signaling pathway. Int. J. Mol. Med. 2010, 25, 923-927. [CrossRef] [PubMed]
56. Chou, D.S.; Hsiao, G.; Lai, Y.A.; Tsai, Y.J.; Sheu, J.R. Baicalein induces proliferation inhibition in B16F10 melanoma cells by generating reactive oxygen species via 12-lipoxygenase. Free Radic. Biol. Med. 2009, 46, 1197-1203. [CrossRef] [PubMed]
57. Yamashita, S.; Baba, K.; Makio, A.; Kumazoe, M.; Huang, Y.; Lin, I.C.; Bae, J.; Murata, M.; Yamada, S.; Tachibana, H.-Tocotrienol upregulates aryl hydrocarbon receptor expression and enhances the anticancer effect of baicalein. Biochem. Biophys. Res. Commun. 2016, 473, 801-807. [CrossRef] [PubMed]
58. Ma, G.Z.; Liu, C.H.; Wei, B.; Qiao, J.; Lu, T.; Wei, H.C.; Chen, H.D.; He, C.D. Baicalein inhibits DMBA/TPA-induced skin tumorigenesis in mice by modulating proliferation, apoptosis, and inflammation. Inflammation 2013, 36, 457-467. [CrossRef] [PubMed]
59. Wu, B.; Li, J.; Huang, D.; Wang, W.; Chen, Y.; Liao, Y.; Tang, X.; Xie, H.; Tang, F. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. BMC Cancer 2011, 11, 527. [CrossRef] [PubMed]
60. Hallek, M.; Bergsagel, P.L.; Andeson, K.C. Multiple Myeloma: Increasing evidence for a multistep transformation process. Blood 1998, 91, 3-21. [PubMed]
61. Lin, M.G.; Liu, L.P.; Li, C.Y.; Zhang, M.; Chen, Y.; Qin, J.; Gu, Y.Y.; Li, Z.; Wu, X.L.; Mo, S.L. Scutellaria extract decreases the proportion of side population cells in a myeloma cell line by down-regulating the expression of ABCG2 protein. Asian Pac. J. Cancer Prev. 2013, 14, 7179-7186. [CrossRef] [PubMed]
62. Gu, Y.Y.; Liu, L.P.; Qin, J.; Zhang, M.; Chen, Y.; Wang, D.; Li, Z.; Tang, J.Z.; Mo, S.L. Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro. Fitoterapia 2014, 94, 21-28. [CrossRef] [PubMed]
63. Ma, Z.; Otsuyama, K.; Liu, S.; Abroun, S.; Ishikawa, H.; Tsuyama, N.; Obata, M.; Li, F.J.; Zheng, X.; Maki, Y.; et al. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood 2005, 105, 3312-3318. [CrossRef] [PubMed]
64. Liu, S.; Ma, Z.; Cai, H.; Li, Q.; Rong,W.; Kawano, M. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells. Eur. J. Haematol. 2010, 84, 137-144. [CrossRef] [PubMed]
65. Otsuyama, K.I.; Ma, Z.; Abroun, S.; Amin, J.; Shamsasenjan, K.; Asaoku, H.; Kawano, M.M. PPARα-mediated growth suppression of baicalein and dexamethasone in human myeloma cells. Leukemia 2007, 21, 187-190. [CrossRef] [PubMed]
66. Bielack, S.S.; Kempf-Bielack, B.; Delling, M.; Ulrich Exner, G.; Flege, S.; Helmke, K.; Kotz, R.; Salzer-Kuntschik, M.; Werner, M.; Winfried, W.; et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 2002, 20, 776-790. [CrossRef] [PubMed]
67. Zhang, R.B.; He, L.; Huang, Z.; Ma, Z.; Liu, S.Q. Synergistic effect and mechanism of baicalein in combination with lenalidomide-induced apoptosis of myeloma cells. Zhonghua Xue Ye Xue Za Zhi 2013, 34, 546-547. (In Chinese) [PubMed]
68. Xu, C.P.; Cai, H.L.; He, L.; Ma, Z.; Liu, S.Q. Effect of baicalein on proliferation and migration in multiplemyeloma cell lines RPMI 8226 and U266 cells. Zhonghua Xue Ye Xue Za Zhi 2012, 33, 938-943. (In Chinese) [PubMed]
69. Longhi, A.; Errani, C.; De Paolis, M.; Mercuri, M.; Bacci, G. Primary bone osteosarcoma in the pediatric age:State of the art. Cancer Treat. Rev. 2006, 32, 423-436. [CrossRef] [PubMed]
70. Ye, F.; Wang, H.; Zhang, L.; Zou, Y.; Han, H.; Huang, J. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression. Tumor Biol. 2015, 36, 4731-4740. [CrossRef] [PubMed]
71. He, N.; Zhang, Z. Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway. Mol. Cell. Biochem. 2015, 405, 187-196. [CrossRef] [PubMed]
72. Zhang, Y.; Song, L.; Cai, L.; Wei, R.; Hu, H.; Jin, W. Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells. Food Chem. Toxicol. 2013, 53, 325-333. [CrossRef] [PubMed]
73. Ding, L.; He, S.; Sun, X. HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis. Apoptosis 2014, 19, 1269-1280. [CrossRef] [PubMed]
74. Weng, C.J.; Yen, G.C. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 2012, 38, 76-87. [CrossRef] [PubMed]
75. He, Z.; Li, B.; Rankin, G.O.; Rojanasakul, Y.; Chen, Y.C. Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells. Oncol. Lett. 2015, 9, 1444-1450. [CrossRef] [PubMed]
76. Chen, J.; Li, Z.; Chen, A.Y.; Ye, X.; Luo, H.; Rankin, G.O.; Chen, Y.C. Inhibitory effect of baicalin and baicalein on ovarian cancer cells. Int. J. Mol. Sci. 2013, 14, 6012-6025. [CrossRef] [PubMed]
77. Yan, H.; Xin, S.; Wang, H.; Ma, J.; Zhang, H.; Wei, H. Baicalein inhibits MMP-2 expression in human ovarian cancer cells by suppressing the p38 MAPK-dependent NF-κB signaling pathway. Anticancer Drugs 2015, 26, 649-656. [CrossRef] [PubMed]
78. Donald, G.; Hertzer, K.; Eibl, G. Baicalein-An Intriguing Therapeutic Phytochemical in Pancreatic Cancer. Curr. Drug Targets 2012, 13, 1772-1776. [CrossRef] [PubMed]
79. Jemal, A.; Murray, T.; Samuels, A.; Ghafoor, A.; Ward, E.; Thun, M.J. Cancer Statistics, 2003. CA Cancer J. Clin. 2003, 53, 5-26. [CrossRef] [PubMed]
80. Ding, X.Z.; Kuszynski, C.A.; El-Metwally, T.H.; Adrian, T.E. Lipoxygenase Inhibition Induced Apoptosis, Morphological Changes, and Carbonic Anhydrase Expression in Human Pancreatic Cancer Cells. Biochem. Biophys. Res. Commun. 1999, 266, 392-399. [CrossRef] [PubMed]
81. Tong, W.G.; Ding, X.Z.; Witt, R.C.; Adrian, T.E. Lipoxygenase Inhibitors Attenuate Growth of Human Pancreatic Cancer Xenografts and Induce Apoptosis through the Mitochondrial Pathway. Mol. Cancer Ther. 2002, 1, 929-935. [PubMed]
82. Takahashi, H.; Chen, M.C.; Pham, H.; Angst, E.; King, J.C.; Park, J.; Brovman, E.Y.; Ishiguro, H.; Harris, D.M.; Reber, H.A.; et al. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim. Biophys. Acta 2011, 1813, 1465-1474. [CrossRef] [PubMed]
83. Miocinovic, R.; McCabe, N.P.; Keck, R.W.; Jankun, J.; Hampton, J.A.; Selman, S.H. In vivo and in vitro effect of baicalein on human prostate cancer cells. Int. J. Oncol. 2005, 26, 241-246. [CrossRef] [PubMed]
84. Pidgeon, G.P.; Kandouz, M.; Meram, A.; Honn, K.V. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-Lipoxygenase inhibition in prostate cancer cells. Cancer Res. 2002, 62, 2721-2727. [PubMed]
85. Taniguchi, H.; Yoshida, T.; Horinaka, M.; Yasuda, T.; Goda, A.E.; Konishi, M.; Wakada, M.; Kataoka, K.; Yoshikawa, T.; Sakai, T. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res. 2008, 68, 8918-8927. [CrossRef] [PubMed]
86. Lovey, J.; Nie, D.; Tovari, J.; Kenessey, I.; Timar, J.; Kandouz, M.; Honn, K.V. Radiosensitivity of human prostate cancer cells can be modulated by inhibition of 12-lipoxygenase. Cancer Lett. 2013, 335, 495-501. [CrossRef] [PubMed]
87. Aryal, P.; Kim, K.; Park, P.H.; Ham, S.; Cho, J.; Song, K. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells. FEBS J. 2014, 281, 4644-4658. [CrossRef] [PubMed]
88. Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87-108. [CrossRef] [PubMed]
89. Gao, J.; Morgan, W.A.; Sanchez-Medina, A.; Corcoran, O. The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. Toxicol. Appl. Pharmacol. 2011, 254, 221-228. [CrossRef] [PubMed]
90. Gao, J.; Zhao, H.; Hylands, P.J.; Corcoran, O. Secondary metabolite mapping identifies Scutellaria inhibitors of human lung cancer cells. J. Pharm. Biomed. Anal. 2010, 53, 723-728. [CrossRef] [PubMed]
91. Leung, H.W.; Yang, W.H.; Lai, M.Y.; Lin, C.J.; Lee, H.Z. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem. Toxicol. 2007, 45, 403-411. [CrossRef] [PubMed]
92. Lee, H.Z.; Leung, H.W.; Lai, M.Y.; Wu, C.H. Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res. 2005, 25, 959-964. [PubMed]
93. Naveenkumar, C.; Asokkumar, S.; Raghunandhakumar, S.; Jagan, S.; Anandakumar, P.; Augustine, T.A.; Kamaraj, S.; Devaki, T. Potent antitumor and antineoplastic efficacy of baicalein on benzo(a)pyrene-induced experimental pulmonary tumorigenesis. Fundam. Clin. Pharmacol. 2012, 26, 259-270. [CrossRef] [PubMed]
94. Naveenkumar, C.; Raghunandhakumar, S.; Asokkumar, S.; Devaki, T. Baicalein Abrogates Reactive Oxygen Species (ROS)-mediated Mitochondrial Dysfunction during Experimental Pulmonary Carcinogenesis in Vivo. Basic Clin. Pharmacol. Toxicol. 2013, 112, 270-281. [CrossRef] [PubMed]
95. Naveenkumar, C.; Raghunandakumar, S.; Asokkumar, S.; Binuclara, J.; Rajan, B.; Premkumar, T.; Devaki, T. Mitigating role of baicalein on lysosomal enzymes and xenobiotic metabolizing enzyme status during lung carcinogenesis of Swiss albino mice induced by benzo(a)pyrene. Fundam. Clin. Pharmacol. 2014, 28, 310-322. [CrossRef] [PubMed]
96. Zheng, F.; Wu, J.; Zhao, S.; Luo, Q.; Tang, Q.; Yang, L.; Li, L.; Wu, W.; Hann, S.S. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells. J. Exp. Clin. Cancer Res. 2015, 34, 41. [CrossRef] [PubMed]
97. Wang, W.; Xi, M.; Duan, X.; Wang, Y.; Kong, F. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: Synergistic antitumor effect in vitro and in vivo. Int. J. Nanomed. 2015, 10, 3737-3750.
98. Xu, X.M.; Yuan, G.J.; Deng, J.J.; Guo, H.T.; Xiang, M.; Yang, F. Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo. Hepatobiliary Pancreat. Dis. Int. 2012, 11, 193-202. [CrossRef]
99. Liang, R.R.; Zhang, S.; Qi, J.A.; Wang, Z.D.; Li, J.; Liu, P.J. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling. Int. J. Oncol. 2012, 41, 969-978. [PubMed]
100. Lee, M.J.; Wang, C.J.; Tsai, Y.Y.; Hwang, J.M.; Lin, W.L.; Tseng, T.H.; Chu, C.Y. Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by baicalein. Nutr. Cancer 1999, 34, 185-191. [CrossRef] [PubMed]
101. Bonham, M.; Posakony, J.; Coleman, I.; Montgomery, B.; Simon, J.; Nelson, P.S. Characterization of Chemical Constituents in Scutellaria baicalensis with Antiandrogenic and Growth-Inhibitory Activities toward Prostate Carcinoma. Clin. Cancer Res. 2005, 11, 3905-3914. [CrossRef] [PubMed]